Navigation Links
Week One of All Things Medical Auction Event Starts Monday, March 11, 2013 Conducted by IpAuctions™, Inc.

Reno, NV (PRWEB) March 11, 2013

IpAuctions™, Inc. is proud to conduct the first annual All Things Medical and will be featuring the University of Arkansas to kick off the event. The Board of Trustees of the University of Arkansas is offering the following patents and applications.

Lot#1208 Human Cytoplasmic Polyadenylation Element Binding Protein Patent Portfolio.

Includes 3 US patents. Diagnostic and/or Therapeutic Tool - This discovery relates to the fields of molecular biology and gene cloning. Specifically relating to the identification, cloning, and characterization of the gene encoding human cytoplasmic polyadenylation element binding protein (hCPEB), with sequence-specific RNA binding activity.

Lot#1209 Patent for Diagnosis of Atypical Mycobacterial Infections.

Includes a single US patent. This novel method amplifies the rDNA of eleven different MOTT species in a single test and does not amplify M. tuberculosis DNA. This test can be applied directly on patient samples, both fresh and formalin-fixed, which greatly decreases the turnaround time.

Lot# 1210 Medical Patent For Method of Diagnosing Heart Disease.

Includes a single US patent. This invention integrates and refines a battery of sensitive and specific tests based on multi-fractal analysis and applies them to digitized EKG data to generate diagnostic/prognostic information. Useful results from these tests can be made available in 15 minutes or less (multi-fractal alpha – MFalpha) to several hours (MF Holder, or the related MF Cascade Coefficient, MFCC).

Lot#1211 Ovarian Cancer Diagnosis Portfolio.

Includes patents and patent applications in the US, Canada, Australia, European and WIPO. Now the University of Arkansas Biochemistry and Molecular Biology department has developed this ‘marker’, ready for further development and trials. The disclosed nucleic acid primer sets, used in combination with quantitative amplification (PCR) of tissue cDNA, can indicate the presence of specific proteases in a tissue sample. The detected proteases are themselves specifically over-expressed in certain cancers, and the presence of their genetic precursors may serve for early detection of associated ovarian and other malignancies, and for the design of interactive therapies for cancer treatment.

Auctions open at Noon PST.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. IpAuctions™, Inc. "All Things Medical" Auction event is opening March, 2013.
2. Roche NimbleGen and BGI Develop Advanced MHC Region Capture Technology for Human Disease and Biomedical Research
3. DiaTech Life Sciences Announces Medical Advisory Board
4. Van Andel Institute Partners with UNCF to Recruit Students to Biomedical Research Careers
5. Breaking Study: ICU Medicals Tego® Needlefree Connector Proves More Cost Effective Than Traditional Central Venous Catheter Locks
6. China Sky One Medical to Jointly Launch Adult Stem Cell Research Enterprise
7. Varian Medical Systems Schedules First Quarter FY2012 News Release and Conference Call
8. HealthCare Institute of New Jersey Releases 2011 Biopharmaceutical and Medical Technology Economic Impact Data
9. Saladax Biomedical, Inc. to Present at Biotech Showcase™ 2012
10. Live Press Briefing on Findings of Biomedical Industry CEO Survey
11. Saladax Biomedical, Inc. Issued Six Patents Containing Broad Claims in the Immunoassay Space
Post Your Comments:
(Date:11/26/2015)... , England , November 26, 2015 ... Lightpoint Medical, an innovative medical device company specializing in imaging ... grant from the European Commission as part of the Horizon ... the company to carry out a large-scale clinical trial in ... -->      (Logo: , --> ...
(Date:11/25/2015)... , November 25, 2015 2 ... première fois les différences entre les souches bactériennes ... celles des êtres humains . Ces recherches ... et envisager la prise en charge efficace de ... diagnostiqués chez les chats .    --> ...
(Date:11/25/2015)... 25, 2015  Neurocrine Biosciences, Inc. (Nasdaq: NBIX ... and CEO of Neurocrine Biosciences, will be presenting at ... New York . .   ... approximately 5 minutes prior to the presentation to download ... presentation will be available on the website approximately one ...
(Date:11/25/2015)... , Nov. 25, 2015 Orexigen® Therapeutics, Inc. ... participate in a fireside chat discussion at the Piper ... York . The discussion is scheduled for Wednesday, ... .  A replay will be available for ... Stilwell  , Julie NormartVP, Corporate Communications and Business ...
Breaking Biology Technology:
(Date:11/10/2015)... 10, 2015 About signature ... helps to identify and verify the identity of ... as the secure and accurate method of authentication ... particular individual because each individual,s signature is highly ... when dynamic signature of an individual is compared ...
(Date:11/4/2015)... New York , November 4, 2015 ... to a new market report published by Transparency Market ... Share, Growth, Trends and Forecast 2015 - 2022", the global ... of US$ 30.3 bn by 2022. The market is ... the forecast period from 2015 to 2022. Rising security ...
(Date:10/29/2015)... 29, 2015  The J. Craig Venter Institute (JCVI) ... Synthesis and Biosecurity: Lessons Learned and Options for the ... and Human Services guidance for synthetic biology providers has ... --> --> Synthetic biology ... potential to pose unique biosecurity threats. It now is ...
Breaking Biology News(10 mins):